{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/0185cea5-9e3b-4b82-a887-26f91f92765f/7fe09551-ca75-41fa-b6e7-1a8888b26a78?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Coronapod: Old treatments and new hopes","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f3b71a8cbe675f3cedcb/61b9f40a770100001581808f.jpg?height=200","description":"<p>Benjamin Thompson, Noah Baker, and Amy Maxmen discuss efforts to develop treatments for COVID-19.</p><p><br></p><p><strong>In this episode:</strong></p><p><br></p><p><strong>02:00 A push for plasma</strong></p><p>In New York, hospitals are preparing to infuse patients with the antibody-rich blood plasma of people who have recovered from COVID-19. This approach has been used during disease outbreaks for over a century and we discuss how it works, and how effective is might be.</p><p><br></p><p>We also talk about how drug trials for potential treatments are progressing, how scientists are pulling together, and what COVID-19 outbreaks on cruise ships are telling epidemiologists.</p><p><em>News article: </em><a href=\"https://www.nature.com/articles/d41586-020-00895-8\" rel=\"noopener noreferrer\" target=\"_blank\"><em>How blood from coronavirus survivors might save lives</em></a>; <em>News article: </em><a href=\"https://www.nature.com/articles/d41586-020-00885-w\" rel=\"noopener noreferrer\" target=\"_blank\"><em>What the cruise-ship outbreaks reveal about COVID-19</em></a></p><p><br></p><p><strong>18:44 Switching focus</strong></p><p>In the wake of the outbreak, academics are coming together to meet the challenge of the pandemic. We speak to an immunologist and a bioengineer who have changed their research focus and are putting their expertise into action.</p><p><br></p><p><a href=\"https://go.nature.com/get-the-nature-briefing\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.</em></a></p>","author_name":"Springer Nature Limited"}